Acrylic Acid Ethyl Ester

Acrylic Acid Ethyl Ester

SCHEMBL423013

C=CC(=O)OCC.CN(C)C

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 8/20 0.54
HPGD P15428 1/20 0.54
ALDH1A1 P00352 8/20 0.48
TP53 P04637 3/20 0.48
HIF1A Q16665 3/20 0.48
CYP3A4 P08684 2/20 0.48
HSD17B10 Q99714 2/20 0.48
HCAR2 Q8TDS4 1/20 0.46
NPSR1 Q6W5P4 1/20 0.45
THRB P10828 1/20 0.44
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 1/20 0.40
ALOX15 P16050 1/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
SOAT1 P35610 1/20 0.39
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid Ethyl Ester SCHEMBL2379322 0.98 TSHR (0.52) TSHRHPGDALDH1A1TP53HIF1A
Acrylic Acid Ethyl Ester SCHEMBL27639683 0.96 TSHR (0.50) TSHRHPGDALDH1A1TP53HIF1A
Acrylic Acid Ethyl Ester SCHEMBL3180 0.93
Acrylic Acid Ethyl Ester SCHEMBL8159679 0.93 TSHR (0.60) TSHRHPGDALDH1A1TP53HIF1A
Acrylic Acid Ethyl Ester SCHEMBL9557413 0.93 TSHR (0.60) TSHRHPGDALDH1A1TP53HIF1A
Acrylic Acid Ethyl Ester SCHEMBL8026038 0.92 TSHR (0.47) TSHRHPGDALDH1A1TP53HIF1A
Acrylic Acid Ethyl Ester SCHEMBL8026032 0.92 TSHR (0.47) TSHRHPGDALDH1A1TP53HIF1A
Acrylic Acid Ethyl Ester SCHEMBL8026034 0.92 TSHR (0.47) TSHRHPGDALDH1A1TP53HIF1A
Acrylic Acid Ethyl Ester SCHEMBL444412 0.91 TSHR (0.50) TSHRHPGDALDH1A1TP53HIF1A
Acrylic Acid Ethyl Ester SCHEMBL23607549 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 373 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3854933-B1 MANUFACTURE OF ELECTRO-MAGNETIC SHIELDING TEXTILES WITH CONDUCTIVE ORGANIC POLYMERIC COATING SRI CENTER FOR PHYSICAL SCIENCES AND TECH (LT) 2024-08-07 EP claimed
CN-118339268-A Detergent composition 宝洁公司 2024-07-12 CN claimed
CN-116813835-A Preparation method of polyacrylamide emulsion for oil field 西安天正石油技术有限公司 2023-09-29 CN claimed
CN-116438283-A Color care detergent composition 宝洁公司 2023-07-14 CN claimed
EP-1825884-B1 Brightening and/or colouring agent with reduced potential for irritation HENKEL AG & CO KGAA (DE) 2017-08-16 EP claimed
US-9708562-B2 Rapidly inverting water-in-oil polymer emulsions SOANE ENERGY, LLC (US) 2017-07-18 US claimed
EP-1813260-B1 Bleaching and/or colouring agent with reduced potential for irritation HENKEL AG & CO KGAA (DE) 2017-05-31 EP claimed
EP-1976888-B1 PROCESS FOR PREPARING A COPOLYMER WITH CONTROLLED ARCHITECTURE, OF TELOMER OR BLOCK COPOLYMER TYPE, OBTAINED FROM VINYL PHOSPHONATE MONOMERS, BY IODINE TRANSFER POLYMERIZATION RHODIA OPERATIONS (FR) 2012-06-13 EP claimed
EP-1674071-B1 Composition comprising a block copolymer, an aminosilicone and an non polymeric thickener and uses OREAL (FR) 2010-07-28 EP claimed
US-20100160574-A1 Polymerisation Using Chain Transfer Agents THE UNIVERSITY OF LEEDS (GB) 2010-06-24 US claimed
US-20040115498-A1 Composite proton exchange membrane and method of manufacturing the same GINER ELX SUB, INC. 2004-06-17 US claimed
WO-2004042845-A2 COMPOSITE PROTON EXCHANGE MEMBRANE AND METHOD OF MANUFACTURING THE SAME GINER ELECTROCHEMICAL SYSTEMS, LLC (US) 2004-05-21 WO claimed
EP-0900563-B1 Production of pharmaceutical formulations containing aescin for treatment of edema and venous disorders KLINGE CO CHEM PHARM FAB (DE) 2004-02-11 EP claimed
EP-1383813-A2 USE OF AMPHILIC BLOCK COPOLYMERS IN ORDER TO INCREASE THE WATER AFFINITY OF LOW-ENERGY SURFACES RHODIA CHIMIE (FR) 2004-01-28 EP claimed
WO-2003025031-A1 EMULSIONS HAVING ACTIVATING AGENTS OF ALKOXYLATES OF 6,6-DIMETHYLBICYCLO [3.1.1]HEPT-2-ENE-2-ETHANOL RHODIA INC. (US) 2003-03-27 WO claimed
US-6476168-B1 Emulsions having activating agents of alkoxylates of 6, 6-dimethylbicyclo [3.1.1] hept-2-ene-2-ethanol RHODIA, INC. 2002-11-05 US claimed
WO-2002068487-A2 USE OF AMPHILIC BLOCK COPOLYMERS IN ORDER TO INCREASE THE WATER AFFINITY OF LOW-ENERGY SURFACES RHODIA CHIMIE (FR) 2002-09-06 WO claimed
US-6077534-A ADMINISTERING ESCIN; SOLVENT EXTRACTION OF HORSE CHESTNUT SEEDS; MIXING WITH DEXTRIN; PELLETIZATION, DRYING, SIEVING, COATING KLINGE PHARMA GMBH (DE) 2000-06-20 US claimed
US-5925714-A USING ALKOXYLATED CASTOR OIL AS BIODEGRADABLE SURFACTANT RELEASE OR ACTIVATION AGENT FOR INVERSION OF WATER IN OIL EMULSION OF WATER SOLUBLE SUBSTITUTED POLY(METH)ACRYLAMIDES, THICKENERS, FLOCCULATING AGENTS, WASTE WATER TREATMENT SNF S.A. (FR) 1999-07-20 US claimed
EP-0900563-A1 Production of pharmaceutical formulations containing aescin for treatment of edema and venous disorders Klinge Pharma GmbH (DE) 1999-03-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160574-A1 Polymerisation Using Chain Transfer Agents TRRAP, TRMT1, IPO11 TSHR 1796/4885HPGD 2331/4885ALDH1A1 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.